$SLN Surges 125% on Merck M&A Takeover Offer: Closing Auction Liquidity Analysis
$SLN closes up 125.58% at $19.58 following a validated 130% premium acquisition offer from Merck, anchoring today's primary liquidity and session momentum.
$EYPT
$EYPT Breakout & Liquidity Hub
EyePoint, Inc. • Tracked across 2 quantitative market dispatch(es)
Last Observed Price$0.3121
Intraday Delta-2.32%
Session Volume935,414
Relative Volume (RVOL)0.18x Baseline
01 // 5-Layer AI Attribution & SEC Dilution Audit
EDGAR + TAPE TELEMETRYLAYER 01 // CATALYST & VERDICT
Synchronizing SEC EDGAR 8-K filings, press wires, and real-time catalyst attribution for $EYPT...
LAYER 05 // SEC DILUTION & SHELF RISKLOW DILUTION
Composite SEC Risk Rating
Scanning S-3 shelf registrations, 424B5 ATM capacity, and listing compliance...
LAYER 02 // TECHNICAL PIVOTS & RVOLINTRADAY TAPE
Relative Volume0.18x
VWAP Divergence
52W High Structure
RSI (14) Momentum
LAYERS 03–04 // LIQUIDITY & ORDER FLOWFLOW SCAN
Free Float Tier
Float Turnover %
Dollar Volume
Short Interest (% Float)
02 // Multi-Timeframe Technical Workspace
03 // Market Intelligence & Anomaly Scans
$SLN Institutional Block Accumulation Tests $20 Merck Deal Threshold (+125.58%)
$SLN surges 125.58% on 71.9M shares following a 130% buyout offer from Merck, with afternoon tape pressure pushing toward the $20 deal pivot.